Abingdon Health Plc (LON:ABDX – Get Free Report) dropped 4.8% on Thursday . The company traded as low as GBX 10 ($0.12) and last traded at GBX 10 ($0.12). Approximately 217,062 shares traded hands during mid-day trading, a decline of 36% from the average daily volume of 337,357 shares. The stock had previously closed at GBX 10.50 ($0.13).
Abingdon Health Price Performance
The stock has a market cap of £12.17 million, a price-to-earnings ratio of -1,000.00 and a beta of 0.13. The company has a quick ratio of 1.96, a current ratio of 1.79 and a debt-to-equity ratio of 55.57. The company’s 50-day moving average is GBX 9.04 and its 200-day moving average is GBX 9.50.
About Abingdon Health
Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides Abingdon Simply Test, a range of self-tests in the field of fertility, health and well-being, infectious diseases, and drug testing; PCRD and PCRD FLEX, are nucleic acid lateral flow tests, which are used for rapid readouts post isothermal amplification; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2, as well as plant health tests; and nucleic acid lateral flow immunoassays.
Further Reading
- Five stocks we like better than Abingdon Health
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Hasbro’s Management Made All the Right Calls This Quarter
- Market Cap Calculator: How to Calculate Market Cap
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- Stock Market Upgrades: What Are They?
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
